COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
'''Dermatologic Disorders of COVID-19 Team Members''' | '''Dermatologic Disorders of COVID-19 Team Members''' | ||
*'''Aditya Ganti''' | *'''[[User:Aditya Ganti|Aditya Ganti, M.B.B.S.]]''' | ||
*[[user:Nuha|Nuha AL-Howthi, MD]] | *[[user:Nuha|Nuha AL-Howthi, MD]] | ||
*[[Ogechukwu Hannah Nnabude, MD]] | *[[Ogechukwu Hannah Nnabude, MD]] | ||
| Line 49: | Line 49: | ||
'''Hematologic disorders of COVID-19 Team Members''' | '''Hematologic disorders of COVID-19 Team Members''' | ||
*'''Ramyar Ghandriz''' | *'''[[User:Ramyar Ghandriz|Ramyar Ghandriz, M.D.]]''' | ||
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]] | * [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]] | ||
*Shakiba Hassanzadeh | *Shakiba Hassanzadeh | ||
| Line 61: | Line 61: | ||
'''Neurologic Disorders and COVID-19 Team Members''' | '''Neurologic Disorders and COVID-19 Team Members''' | ||
*''' | *'''[[User:Fahimeh Shojaei |Fahimeh Alsadat Shojaei, M.D.]]''' | ||
*'''Syed Musadiq Ali, | *'''[[User:Syed Musadiq Ali|Syed Musadiq Ali, M.D.]]''' | ||
*'''Niloofarsadaat Eshaghhosseiny''' | *'''[[User:Niloofarsadaat Eshaghhosseiny|Niloofarsadaat Eshagh Hosseiny, M.D.]]''' | ||
*Muhammad Adnan Haider | *Muhammad Adnan Haider | ||
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]] | *[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]] | ||
| Line 72: | Line 72: | ||
'''Pediatrics and COVID-19''' | '''Pediatrics and COVID-19''' | ||
*'''Abdelrahman | *'''[[Abdelrahman Ibrahim Abushouk|Abdelrahman Ibrahim Abushouk, M.D.]]''' | ||
* [[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]] | * [[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]] | ||
'''Pulmonary Disorders and COVID-19 Team Members''' | '''Pulmonary Disorders and COVID-19 Team Members''' | ||
*'''Sara Mohsin''' | *'''[[User:Sara Mohsin|Sara Mohsin, M.B.B.S.]]''' | ||
* Ayesha Farheen Javid | * Ayesha Farheen Javid | ||
* Usman Ali akbar | * Usman Ali akbar | ||
Revision as of 15:56, 17 June 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
Associate Editor(s)-in-Chief:
- The name of the leaders are written in bold:
Cardiovascular Disorders of COVID-19 Team Members
- Alieh Bahjat
- Mandana Chitsazan, M.D.
- Mitra Chitsazan
- Mandana Safakhah
- Mounika Vadiyala
- Sara Haddadi
- Sara Zand
- Syed Rizvi
- Tayyaba Ali, M.D.
Dermatologic Disorders of COVID-19 Team Members
Frequently Asked Inpatient Questions Team Members
- Gurmandeep Singh Sandhu, M.B.B.S.
- Aisha Adigun, M.D.
- Harmeet Kharoud, M.D,. MPH
- Rinky Agnes Botleroo, M.B.B.S.
- Nuha AL-Howthi, MD
- Ifrah Fatima, M.B.B.S
- Ogechukwu Hannah Nnabude, MD
Frequently Asked Outpatient Questions Team Members
- Roukoz Abou Karam, M.D.
- Aisha Adigun, M.D.
- Bosky Soni, M.D., MPH
- Neepa Shah, M.D
- Indhumathi Venkatasubramani balaraman, M.D.
Gastrointestinal disorders and of COVID-19
- Farima Kahe
- Tayyaba Ali, M.D.
Hematologic disorders of COVID-19 Team Members
- Ramyar Ghandriz, M.D.
- Ifrah Fatima, M.B.B.S
- Shakiba Hassanzadeh
- Fausat Adogba
Nephrologic Disorders of COVID-19 Team Members
- Sogand Goudarzi, M.D.
- Gurmandeep Singh Sandhu, M.B.B.S.
- Nasrin Nikravangolsefid, M.D, MPH
- Mydah Sajid
Neurologic Disorders and COVID-19 Team Members
- Fahimeh Alsadat Shojaei, M.D.
- Syed Musadiq Ali, M.D.
- Niloofarsadaat Eshagh Hosseiny, M.D.
- Muhammad Adnan Haider
- Rinky Agnes Botleroo, M.B.B.S.
Ongoing Clinical Trials of COVID-19 Team Members
Pediatrics and COVID-19
Pulmonary Disorders and COVID-19 Team Members
- Sara Mohsin, M.B.B.S.
- Ayesha Farheen Javid
- Usman Ali akbar
- Rina Ghorpade
- Rana Aljebzi (not trained yet)